This announcement is a separate document:
Cellectar BioSciences | 4: Statement of changes in beneficial ownership of securities-Chief Commercial Officer Lea Darrell Shane
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.